{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:15:57Z","timestamp":1790612157941,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Regulatory T cells (Tregs) are a very specialized subset of T lymphocytes: their main function is controlling immune responses during inflammation. T-regs involvement in autoimmune and immune-mediated rheumatic diseases is well-described. Here, we critically review the up-to-date literature findings on the role of Tregs in spondyloarthropathies, particularly in ankylosing spondylitis (AS), a polygenic inflammatory rheumatic disease that preferentially affects the spine and the sacroiliac joints. Genetics discoveries helped in elucidating pathogenic T-regs gene modules and functional involvement. We highlight T-regs tissue specificity as crucial point, as T-regs might have a distinct epigenomic and molecular profiling depending on the different site of tissue inflammation. Furthermore, we speculate about possible therapeutic interventions targeting, or enhancing, Treg cells in spondyloarthropathies.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1303640","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T23:32:27Z","timestamp":1705275147000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Regulatory T cells in spondyloarthropathies: genetic evidence, functional role, and therapeutic possibilities"],"prefix":"10.3389","volume":"14","author":[{"given":"Stefano","family":"Rodolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Vecellio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214944","article-title":"Identification of myeloid cells in the human enthesis as the main source of local IL-23 production","volume":"78","author":"Bridgewood","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225185","article-title":"Goodbye to the term A\u2019nkylosing spondylitis\u2019, hello A\u2019xial spondyloarthritis\u2019: time to embrace the ASAS-defined nomenclature","author":"van der Heijde","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208640","article-title":"An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation","volume":"75","author":"Roberts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932485","article-title":"Tregs in autoimmunity: insights into intrinsic brake mechanism driving pathogenesis and immune homeostasis","volume":"13","author":"Bednar","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.38291","article-title":"Review: The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/35006090","article-title":"PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes","volume":"404","author":"Sun","year":"2000","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1042\/BST20140167","article-title":"Selective protein kinase Ctheta (PKCtheta) inhibitors for the treatment of autoimmune diseases","volume":"42","author":"Curnock","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/ar793","article-title":"Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis","volume":"5","author":"Duftner","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696973","article-title":"Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: A meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2014.2046","article-title":"T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis","volume":"9","author":"Wang","year":"2015","journal-title":"Exp Ther Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110377","article-title":"Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis","volume":"38","author":"Appel","year":"2011","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","article-title":"What are super-enhancers","volume":"47","author":"Pott","year":"2015","journal-title":"Nat Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-018-8721-0","article-title":"Regulatory T cell plasticity and stability and autoimmune diseases","volume":"58","author":"Qiu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.immuni.2007.09.010","article-title":"Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature","volume":"27","author":"Hill","year":"2007","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr444","article-title":"Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human","volume":"39","author":"Birzele","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218189","article-title":"Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis","volume":"80","author":"Tsuchiya","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07571","article-title":"Genetic and epigenetic variation in the lineage specification of regulatory T cells","volume":"4","author":"Arvey","year":"2015","journal-title":"Elife"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2016.07.37","article-title":"Helios-controller of Treg stability and function","volume":"5","author":"Chougnet","year":"2016","journal-title":"Transl Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200792","article-title":"Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells","volume":"190","author":"Baine","year":"2013","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801270","article-title":"Lack of ikaros deregulates inflammatory gene programs in T cells","volume":"202","author":"Lyon de Ana","year":"2019","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000445","article-title":"Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus","volume":"8","author":"Rivellese","year":"2021","journal-title":"Lupus Sci Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature12199","article-title":"BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis","volume":"498","author":"Roychoudhuri","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0280-9","article-title":"The transcription factor NFIL3 controls regulatory T-cell function and stability","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.717903","article-title":"Tissue tregs and maintenance of tissue homeostasis","volume":"9","author":"Shao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01396-y","article-title":"Tissues, not blood, are where immune cells function","volume":"593","author":"Farber","year":"2021","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500801","article-title":"Control of regulatory T cell migration, function, and homeostasis","volume":"195","author":"Campbell","year":"2015","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220595","article-title":"Macrophages in the synovial lining niche initiate neutrophil recruitment and articular inflammation","volume":"220","author":"Zec","year":"2023","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar3257","article-title":"Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th\/Treg cell subset imbalance in ankylosing spondylitis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s42003-021-02931-3","article-title":"Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates","volume":"4","author":"Simone","year":"2021","journal-title":"Commun Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12016-023-08959-z","article-title":"Single-cell analysis of patients with axial spondyloarthritis after anti-TNFalpha treatment: experimental data and review of the literature","volume":"65","author":"Zhao","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.intimp.2018.03.032","article-title":"Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3","volume":"59","author":"Wang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","article-title":"CD4(+)CD25(+)\/highCD127low\/(-) regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2013analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood","volume":"16","author":"Moradi","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141008","article-title":"IL-1beta-driven osteoclastogenic Tregs accelerate bone erosion in arthritis","volume":"131","author":"Levescot","year":"2021","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13075-020-02226-8","article-title":"TNF-\u03b1 inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis","volume":"22","author":"Yang","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-alpha therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.122.BJR-2022-0195.R1","article-title":"Cytokines and regulatory T cells in ankylosing spondylitis","volume":"12","author":"Liao","year":"2023","journal-title":"Bone Joint Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.01.020","article-title":"Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner","volume":"34","author":"Huber","year":"2011","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s42003-023-04874-3","article-title":"Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells","volume":"6","author":"Kojima","year":"2023","journal-title":"Commun Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956090","article-title":"The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application","volume":"13","author":"Huo","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"102504","DOI":"10.1016\/j.jaut.2020.102504","article-title":"LAG3 (CD223) and autoimmunity: Emerging evidence","volume":"112","author":"Hu","year":"2020","journal-title":"J Autoimmun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2091","article-title":"Depletion of LAG-3(+) T cells translated to pharmacology and improvement in psoriasis disease activity: A phase I randomized study of mAb GSK2831781","volume":"109","author":"Ellis","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/icb.2015.90","article-title":"TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO","volume":"94","author":"Ye","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11926-018-0729-1","article-title":"Functional defects of treg cells: new targets in rheumatic diseases, including ankylosing spondylitis","volume":"20","author":"Miao","year":"2018","journal-title":"Curr Rheumatol Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1303640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T23:32:29Z","timestamp":1705275149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1303640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2023.1303640"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1303640","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1303640"}}